Redmile Group (NASDAQ: ADCT) reports 9.9% stake after SPV reorg

Redmile Group, LLC has disclosed a 9.9% beneficial ownership stake in ADC Therapeutics (NASDAQ: ADCT) following an internal reorganization. This reorganization involved RedCo II Master Fund, L.P. transferring its securities to its wholly-owned SPVs, with RedCo II Offshore SPV LLC now holding 6.1% of ADCT shares. The filing also clarifies that Redmile Group and Jeremy C. Green disclaim direct beneficial ownership beyond their pecuniary interest, and the reported percentage accounts for a Beneficial Ownership Limitation related to pre-funded warrants.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin